PhRMA general counsel is Russel Bantham from Bristol-Myers Squibb.
PhRMA SENIOR VP AND GENERAL COUNSEL BANTHAM JOINS FROM BMS Jan. 23 as successor to Bruce Brennan, who retired at the end of 1994. A six-person search committee advised the Pharmaceutical Research & Manufacturers Association on the selection of Bantham. PhRMA announced Bantham's appointment on Jan. 19. Brennan is practicing private law in Washington, D.C. and serving as a PhRMA consultant.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth